Circadian CLOCK-mediated regulation of target-tissue sensitivity to glucocorticoids: Implications for cardiometabolic diseases

Endocrine Development

Volumn 20, Issue , 2010, Pages 116-126

  Kino, Tomoshige ^a   Chrousos, George P ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HISTONE ACETYLTRANSFERASE; HYDROCORTISONE; LYSINE; TRANSCRIPTION FACTOR CLOCK;

ACETYLATION; ARTICLE; CARDIOMETABOLIC DISEASE; CARDIOVASCULAR DISEASE; CELLULAR DISTRIBUTION; CHRONIC STRESS; CIRCADIAN RHYTHM; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERCORTISOLISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; METABOLIC SYNDROME X; MOLECULAR INTERACTION; NONHUMAN; OSCILLATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; TISSUE SENSITIVITY; WORK SCHEDULE;

ANIMALS; CARDIOVASCULAR DISEASES; CIRCADIAN RHYTHM; CLOCK PROTEINS; DRUG RESISTANCE; GLUCOCORTICOIDS; HUMANS; METABOLIC DISEASES; MODELS, BIOLOGICAL; ORGAN SPECIFICITY;

EID: 78751531109     PISSN: 14217082     EISSN: 16622979     Source Type: Book Series    
DOI: 10.1159/000321232     Document Type: Article

References (48)

1. Kino T, Chrousos GP: Glucocorticoid effects on gene expression; in Steckler T, Kalin NH, Reul JM (eds): Handbook on Stress and the Brain. Amsterdam, Elsevier, 2005, pp 295-312.
2. Chrousos GP: The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995;332:1351-1362.
3. Chrousos GP: Glucocorticoid therapy; in Felig P, Frohman LA (eds): Endocrinology and Metabolism. New York, McGraw-Hill, 2001, pp 609-632.
4. Nader N, Chrousos GP, Kino T: Interactions of the circadian CLOCK system and the HPA axis. Trends Endocrinol Metab 2010;21:277-286.
5. Chrousos GP, Kino T: Intracellular glucocorticoid signaling: a formerly simple system turns stochastic. Sci STKE 2005;304:pe48.
6. Kino T, De Martino MU, Charmandari E, Mirani M, Chrousos GP: Tissue glucocorticoid resistance/hypersensitivity syndromes. J Steroid Biochem Mol Biol 2003;85:457-467.
7. Abel GA, Wochnik GM, Ruegg J, Rouyer A, Holsboer F, Rein T: Activity of the GR in G2 and mitosis. Mol Endocrinol 2001;16:1352-1366.
8. Cidlowski JA, Michaels GA: Alteration in glucocorticoid binding site number during the cell cycle in HeLa cells. Nature 1977;266:643-645.
9. Wurtman RJ: Stress and the adrenocortical control of epinephrine synthesis. Metabolism 2002;51(suppl 1):11-14.
10. Ehrhart-Bornstein M, Bornstein SR: Cross-talk between adrenal medulla and adrenal cortex in stress. Ann NY Acad Sci 2008;1148:112-117.
11. Chrousos GP, Kino T: Glucocorticoid action networks and complex psychiatric and/or somatic disorders. Stress 2007;10:213-219.
12. Nicolaides NC, Galata Z, Kino T, Chrousos GP, Charmandari E: The human glucocorticoid receptor: molecular basis of biologic function. Steroids 2010;75:1-12.
13. Kino T, Su YA, Chrousos GP: Human glucocorticoid receptor isoform β: recent understanding of its potential implications in physiology and pathophysiology. Cell Mol Life Sci 2009;66:3435-3448.
14. Lu NZ, Cidlowski JA: Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. Mol Cell 2005;18:331-342.
15. Kino T, Chrousos GP: Glucocorticoid and mineralocorticoid receptors and associated diseases. Essays Biochem 2004;40:137-155.
16. Nader N, Chrousos GP, Kino T: Circadian rhythm transcription factor CLOCK regulates the transcriptional activity of the glucocorticoid receptor by acetylating its hinge region lysine cluster: potential physiological implications FASEB J 2009;23:1572-1583.
17. Savory JG, Hsu B, Laquian IR, Giffin W, Reich T, Hache RJ, Lefebvre YA: Discrimination between NL1-and NL2-mediated nuclear localization of the glucocorticoid receptor Mol Cell Biol 1999;19:1025- 1037.l
18. Rosenfeld MG, Lunyak VV, Glass CK: Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev 2006;20:1405-1428.
19. Wang Q, Blackford JA Jr, Song LN, Huang Y, Cho S, Simons SS Jr: Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors. Mol Endocrinol 2004;18:1376-1395.
20. Reichardt HM, Kaestner KH, Tuckermann J, Kretz O, Wessely O, Bock R, Gass P, Schmid W, Herrlich P, Angel P, Schutz G: DNA binding of the glucocorticoid receptor is not essential for survival. Cell 1998; 93:531-541.
21. Cole TJ, Blendy JA, Monaghan AP, Krieglstein K, Schmid W, Aguzzi A, Fantuzzi G, Hummler E, Unsicker K, Schutz G: Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev 1995;9:1608-1621.
22. Reichardt HM, Tuckermann JP, Gottlicher M, Vujic M, Weih F, Angel P, Herrlich P, Schutz G: Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. EMBO J 2001;20:7168-7173.
23. Miner JN, Yamamoto KR: Regulatory crosstalk at composite response elements. Trends Biochem Sci 1991;16:423-426.
24. Ogawa S, Lozach J, Benner C, Pascual G, Tangirala RK, Westin S, Hoffmann A, Subramaniam S, David M, Rosenfeld MG, Glass CK: Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 2005;122:707-721.
25. Kino T, Ichijo T, Amin ND, Kesavapany S, Wang Y, Kim N, Rao S, Player A, Zheng YL, Garabedian MJ, Kawasaki E, Pant HC, Chrousos GP: Cyclindependent kinase-5 differentially regulates the transcriptional activity of the glucocorticoid receptor through phosphorylation: clinical implications for the nervous system response to glucocorticoids and stress. Mol Endocrinol 2007;21:552-1568.
26. Nader N, Ng SM, Lambrou GI, Pervanidou P, Wang YH, Chrousos P, Kino T: AMPK regulates metabolic actions of glucocorticoids by phosphorylating the glucocorticoid receptor through p38 MAPK. Mol Endocrinol 2010 (in press).
27. Kino T: Tissue glucocorticoid sensitivity: beyond stochastic regulation on the diverse actions of glucocorticoids. Horm Metab Res 2007;39:420-424.
28. Cermakian N, Sassone-Corsi P Multilevel regulation of the circadian clock. Nat Rev Mol Cell Biol 2000;1:59-67.
29. Ko CH, Takahashi JS: Molecular components of the mammalian circadian clock. Hum Mol Genet 2006; 15:R271-R277.
30. Takahashi JS, Hong HK, Ko CH, McDearmon EL: The genetics of mammalian circadian order and disorder: implications for physiology and disease. Nat Rev Genet 2008;29:764-775.
31. Ralph MR, Foster RG, Davis FC, Menaker M: Transplanted suprachiasmatic nucleus determines circadian period. Science 1990;247.975-978.
32. Rusak B, Zucker I: Neural regulation of circadian rhythms. Physiol Rev 1979;59:449-526.
33. Grimaldi B, Nakahata Y, Sahar S, Kaluzova M, Gauthier D, Pham K, Patel N, Hirayama J, Sassone-Corsi P: Chromatin remodeling and circadian control: master regulator CLOCK is an enzyme. Cold Spring Harb Symp Quant Biol 2007;72:105-112.
34. Hirayama J, Sahar S, Grimaldi B, Tamaru T, Takamatsu K, Nakahata Y, Sassone-Corsi P: CLOCK-mediated acetylation of BMAL1 controls circadian function. Nature 2007;450:1086-1090.
35. Kondratov RV, Kondratova AA, Lee C, Gorbacheva VY, Chernov MV, Antoch MP: Post-translational regulation of circadian transcriptional CLOCK (NPAS2)/BMAL1 complex by cryptochromes. Cell Cycle 2006;5:890-895.
36. Kiyohara YB, Tagao S, Tamanini F, Morita A, Sugisawa Y, Yasuda M, Yamanaka I, Ueda HR, van der Horst GT, Kondo T, Yagita K: The BMAL1 C terminus regulates the circadian transcription feedback loop. Proc Natl Acad Sci USA 2006;103:10074-10079.
37. Doi M, Hirayama J, Sassone-Corsi P: Circadian regulator CLOCK is a histone acetyltransferase. Cell 2006;125:497-508.
38. Ripperger JA, Schibler U: Rhythmic CLOCKBMAL1 binding to multiple E-box motifs drives circadian Dbp transcription and chromatin transitions. Nat Genet 2006;38:369-374.
39. Chrousos GP, Kino T Glucocorticoid action networks and complex psychiatric and/or somatic disorders, Stress 2007;10:213-219.
40. Chrousos GP, Kino T: Glucocorticoid signaling in the cell. Expanding clinical implications to complex human behavioral and somatic disorders. Ann NY Acad Sci 2009;1179:153-166.
41. Yang X, Downes M, Yu RT, Bookout AL, He W, Straume M, Mangelsdorf DJ, Evans RM: Nuclear receptor expression links the circadian clock to metabolism. Cell 2006;126:801-810.
42. Staels B: When the Clock stops ticking, metabolic syndrome explodes. Nat Med 2006;12:54-55.
43. Panda S, Antoch MP, Miller BH, Su AI, Schook AB, Straume M, Schultz PG, Kay SA, Takahashi JS, Hogenesch JB: Coordinated transcription of key pathways in the mouse by the circadian clock. Cell 2002;109:307-320.
44. Storch KF, Lipan O, Leykin I, Viswanathan N, Davis FC, Wong WH, Weitz CJ: Extensive and divergent circadian gene expression in liver and heart. Nature 2002;417:78-83.
45. Ekstrand K, Bostrom PA, Arborelius M, Nilsson JA, Lindell SE: Cardiovascular risk factors in commercial flight aircrew officers compared with those in the general population. Angiology 1996;47:1089-1094.
46. Scheer FA, Hilton MF, Mantzoros CS, Shea SA: Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci USA 2009;106:4453-4458.
47. Hirayama J, Sahar S, Grimaldi B, Tamaru T, Takamatsu K, Nakahata Y, Sassone-Corsi P: CLOCK-mediated acetylation of BMAL1 controls circadian function. Nature 2007;450:1086-1090.
48. Chrousos GP: The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuroendocrine and target tissue-related causes. Int J Obes Relat Metab Disord 2000;24(suppl 2):S50-S55.